Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM)
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2334
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Hepatitis B testing, treatment, and virologic suppression in HIV-infected patients in Cameroon (ANRS 12288 EVOLCAM) ; volume:20 ; number:1 ; day:15 ; month:1 ; year:2020 ; pages:1-10 ; date:12.2020
BMC infectious diseases ; 20, Heft 1 (15.1.2020), 1-10, 12.2020
- Urheber
-
Liégeois, Florian
Boyer, Sylvie
Eymard-Duvernay, Sabrina
Carrieri, Patrizia
Kouanfack, Charles
Domyeum, Jenny
Maradan, Gwenaëlle
Ducos, Jacques
Mpoudi-Ngolé, Eitel
Spire, Bruno
Delaporte, Eric
Kuaban, Christopher
Vidal, Laurent
Laurent, Christian
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s12879-020-4784-7
- URN
-
urn:nbn:de:101:1-2020042003362673526280
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 14.08.2025, 10:45 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Liégeois, Florian
- Boyer, Sylvie
- Eymard-Duvernay, Sabrina
- Carrieri, Patrizia
- Kouanfack, Charles
- Domyeum, Jenny
- Maradan, Gwenaëlle
- Ducos, Jacques
- Mpoudi-Ngolé, Eitel
- Spire, Bruno
- Delaporte, Eric
- Kuaban, Christopher
- Vidal, Laurent
- Laurent, Christian
- SpringerLink (Online service)
Ähnliche Objekte (12)
Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy
Virologic Effectiveness of Abacavir/Lamivudine with Darunavir/Ritonavir Versus Other Protease Inhibitors in Treatment-Experienced HIV-Infected Patients in Clinical Practice
Viral load suppression in HIV-infected adolescents in cameroon: towards achieving the UNAIDS 95% viral suppression target
Factors affecting antiretroviral pharmacokinetics in HIV-infected women with virologic suppression on combination antiretroviral therapy: a cross-sectional study
Immuno-haematologic and virologic responses and predictors of virologic failure in HIV-1 infected adults on first-line antiretroviral therapy in Cameroon
Immunologic and virologic failure after first-line NNRTI-based antiretroviral therapy in Thai HIV-infected children
Immune correlates of CD4 decline in HIV-infected patients experiencing virologic failure before undergoing treatment interruption
Impact of depression and psychosocial management on drug adherence and viral suppression in HIV-infected patients on antiretroviral treatment in Cameroon
Higher red blood cell distribution width is associated with a worse virologic and clinical situation in HIV-infected patients
Immune and virologic responses to Truvada or Combivir as a first-line therapy of HIV-infected, treatment-naïve patients
Rates of switching to second-line antiretroviral therapy and impact of delayed switching on immunologic, virologic, and mortality outcomes among HIV-infected adults with virologic failure in Rakai, Uganda
Hypothalamic–pituitary–adrenal axis suppression by inhaled or nasal corticosteroids in HIV-infected patients
Immunological status and virological suppression among HIV-infected adults on highly active antiretroviral therapy